by Sue Robbins | Jan 27, 2020 | Migraine
Treatment with the orally administered, small-molecule calcitonin gene-related peptide receptor antagonist ubrogepant in patients with acute migraine has been associated with freedom from pain and the absence of the patient-determined most troublesome symptom compared...
by Sue Robbins | Jan 16, 2020 | Migraine
Bodily injuries are an ever-present workplace hazard for professional athletes, a fact Philadelphia sports fans have been reminded of this week. Like Carson Wentz’s concussion that ended the Eagles’ playoff run and Sixers center Joel Embiid’s...
by Sue Robbins | Jan 15, 2020 | Migraine
A systematic review and meta-analysis of data collected from observational cohort studies reveals several clinical and sociodemographic factors are predictors of chronic migraine. The study, published in the International Headache Society’s Cephalalgia, looked at...
by Sue Robbins | Jan 14, 2020 | Migraine
In a study published December 26 in the Journal of Clinical Medicine, researchers tested the effects of cathodal transcranial direct current stimulation (tDCS) in the occipital cortex of 42 patients with episodic migraine. They determined that tDCS applied to this...
by Sue Robbins | Jan 6, 2020 | Migraine
There are now a number of medications that may prevent or alleviate migraines, as well as a wearable nerve-stimulating device that can be activated by a smartphone. If you live with or work with someone who suffers from migraine, there’s something very important you...
